Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study

It is important for clinicians to determine the risk of worsening trajectories in SSc patients. The Scleroderma Clinical Trials Consortium (SCTC) Damage Index (DI) has been developed to quantify organ damage and shows good capability for mortality and morbidity prediction in patients with SSc. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaohua, Xu, Dan, Jiang, Xintong, Li, Ting, Su, Yin, Mu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456668/
https://www.ncbi.nlm.nih.gov/pubmed/36078943
http://dx.doi.org/10.3390/jcm11175013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456668/
https://www.ncbi.nlm.nih.gov/pubmed/36078943
http://dx.doi.org/10.3390/jcm11175013

Ejemplares similares